The lack of HrpA/HrpB TPS in the gonococcus would explain why the gonococcus remains predominantly confined within a vacuole during cellular infection, unlike the meningococcus, which is able to escape, and why the meningococcus, after reaching the cytosol, induces pyroptotic pathways during cellular infection, a phenomenon not described for the gonococcus
Its mechanism of action involves mimicking the naturally occurring GLP-1 hormone, which plays a central role in glucose homeostasis and appetite regulation
Signs Your Dose May Need Adjustment Signs Your Dose May Be Too Low No improvement in sleep quality after 3-4 weeks Minimal energy changes after 6-8 weeks Lab work shows IGF-1 levels unchanged from baseline Signs Your Dose May Be Too High Water retention (puffy hands, ankles, face) Tingling or numbness in extremities Joint stiffness or discomfort Headaches, particularly in the morning Carpal tunnel-like symptoms If you experience these symptoms, contact your provider
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes mellitus, though certain formulations are now licensed for weight management in adults with obesity or overweight with comorbidities